Article Versions Notes

Hsu W-F, Hsu S-C, Chen T-H, Lin C-H, Lin Y-C, Chang Y-W, Wang H-W, Liao Y-M, Lai H-C, Peng C-Y. Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy. Cancers. 2022; 14(20):5083. https://doi.org/10.3390/cancers14205083

Hsu, Wei-Fan, Shih-Chao Hsu, Te-Hong Chen, Chien-Hung Lin, Ying-Chun Lin, Yu-Wei Chang, Hung-Wei Wang, Yu-Min Liao, Hsueh-Chou Lai, and Cheng-Yuan Peng. 2022. "Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy" Cancers 14, no. 20: 5083. https://doi.org/10.3390/cancers14205083

Hsu, W.-F., Hsu, S.-C., Chen, T.-H., Lin, C.-H., Lin, Y.-C., Chang, Y.-W., Wang, H.-W., Liao, Y.-M., Lai, H.-C., & Peng, C.-Y. (2022). Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy. Cancers, 14(20), 5083. https://doi.org/10.3390/cancers14205083